Cloud 3D-QSAR: a web tool for the development of quantitative structure–activity relationship models in drug discovery

Yu-Liang Wang,Fan Wang,Xing-Xing Shi,Chen-Yang Jia,Feng-Xu Wu,Ge-Fei Hao,Guang-Fu Yang

DOI: https://doi.org/10.1093/bib/bbaa276

IF: 9.5

2020-11-03

Briefings in Bioinformatics

Abstract:Abstract Effective drug discovery contributes to the treatment of numerous diseases but is limited by high costs and long cycles. The Quantitative Structure–Activity Relationship (QSAR) method was introduced to evaluate the activity of a large number of compounds virtually, reducing the time and labor costs required for chemical synthesis and experimental determination. Hence, this method increases the efficiency of drug discovery. To meet the needs of researchers to utilize this technology, numerous QSAR-related web servers, such as Web-4D-QSAR and DPubChem, have been developed in recent years. However, none of the servers mentioned above can perform a complete QSAR modeling and supply activity prediction functions. We introduce Cloud 3D-QSAR by integrating the functions of molecular structure generation, alignment, molecular interaction field (MIF) computing and results analysis to provide a one-stop solution. We rigidly validated this server, and the activity prediction correlation was R2 = 0.934 in 834 test molecules. The sensitivity, specificity and accuracy were 86.9%, 94.5% and 91.5%, respectively, with AUC = 0.981, AUCPR = 0.971. The Cloud 3D-QSAR server may facilitate the development of good QSAR models in drug discovery. Our server is free and now available at http://chemyang.ccnu.edu.cn/ccb/server/cloud3dQSAR/ and http://agroda.gzu.edu.cn:9999/ccb/server/cloud3dQSAR/.

biochemical research methods,mathematical & computational biology

What problem does this paper attempt to address?

### Problems the Paper Aims to Solve

This paper introduces a web tool named Cloud 3D-QSAR, which aims to address the challenges in applying Quantitative Structure–Activity Relationship (QSAR) methods in drug discovery. Specifically:

1. **Lowering Technical Barriers**: Traditional QSAR tools are often difficult for non-expert users to utilize. Cloud 3D-QSAR lowers the technical barriers by automating the entire Comparative Molecular Field Analysis (CoMFA) modeling process and providing prediction functions based on previously developed QSAR models.

2. **Improving Efficiency**: Drug discovery is a time-consuming and costly process. By virtually screening the activity of a large number of compounds, it reduces the time and labor costs required for chemical synthesis and experimental measurement, thereby improving the efficiency of drug discovery.

3. **One-Stop Solution**: Existing servers mostly can only calculate molecular descriptors or are limited to specific proteins, and cannot provide prediction functions beyond data. Cloud 3D-QSAR integrates functions such as molecular structure generation, alignment, Molecular Interaction Field (MIF) calculation, and result analysis, providing a one-stop service.

4. **Performance Validation**: Through validation with 834 test molecules, Cloud 3D-QSAR achieved an activity prediction correlation of R²=0.934, with sensitivity, specificity, and accuracy of 86.9%, 94.5%, and 91.5% respectively, AUC=0.981, and AUCPR=0.971. These results indicate its capability to develop high-quality QSAR models.

In summary, Cloud 3D-QSAR aims to simplify the use of QSAR methods, improve the efficiency of drug discovery, and provide researchers with a powerful tool.